AAOpt 2022: Bausch + Lomb enters the canine healthcare landscape with new Project Watson

Video

Albert Swann share details about Bausch + Lomb's new healthcare product line for dogs: Project Watson.

Albert Swann shares about Baush + Lomb's new line of health care products for dogs, Project Watson, during the 2022 American Academy of Optometry Meeting held in San Diego.

Editor's note: This transcript has been edited for clarity.

I'm Albert Swann for Bausch and Lomb. I'm excited to share with you the launch of Project Watson, healthcare products for dogs.

Project Watson began 3 years ago in my search for eye care solutions for my rescue dog, Watson. And with that—and being a veteran of Bausch and Lomb for over 14 years—I looked internally at the eye health experts of Bausch and Lomb.

We've now developed 6 products to launch for the often overlooked areas of your dog's health: the eyes, the ears, and their overall well-being, with an eyewash an eye wipe, and eye supplements to help support eye health, especially as your dog ages.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
© 2025 MJH Life Sciences

All rights reserved.